Investor Relations

Investor Relations

Company Overview

Avalo Therapeutics, Inc. (AVTX) is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in the areas of Immunology, Immuno-oncology, and Rare Genetic Diseases.

Stock Information

Nasdaq: AVTX Avalo Therapeutics, Inc.
Price
Change
Volume
Day Range
52 Week Range